Misoprostol
Survey: Many pharmacists willing to prescribe medication abortion drugs but need training
More than two-thirds of pharmacists in California surveyed said they would be willing to prescribe medication abortion, if legally permitted, but more than half reported lacking confidence in their knowledge of abortion drugs.
Self-managed abortion medication distribution outside formal settings rose after Dobbs
Distribution of medication for self-managed abortion from sources outside of formal health care settings increased 6 months after the Dobbs decision, despite state-level bans and restrictions, according to findings published in JAMA.
Similar time to delivery with 25 µg, 50 µg misoprostol for women with obesity
Among women with obesity, 50 µg and 25 µg vaginal misoprostol were associated with similar time to delivery, but multiparous women had significantly reduced time to delivery with 50 µg, according to data presented at The Pregnancy Meeting.
Telemedicine requests for advance abortion medication rise after Dobbs
Telemedicine requests for advance provision of abortion medications increased following Dobbs and FDA mifepristone rulings, according to study results published in JAMA Internal Medicine.
Top in women's health: Residents alter plans after Dobbs; misoprostol alone is effective
In a recent survey, nearly 18% of OB/GYN residents reported that the Dobbs decision impacted their plans for practice or fellowship.